CINCINNATI—Researchers at the University of Cincinnati (UC) have found a potential genetic target for heart disease, which could lead to therapies to prevent the development of the nation's No. 1 killer in its initial stages.
These findings will be presented for the first time at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 17.
Being able to read and understand words like anemia, hormones and seizure means a patient with heart failure may be less likely to be hospitalized, according to a new study from Emory University School of Medicine. Findings will be presented Nov. 17 at the American Heart Association Scientific Sessions conference in Chicago.
Tiny particles used in a range of everyday products from computers to shampoo can adversely affect the lungs in very different ways, a study has shown.
Research by the University of Edinburgh suggests that industrial manufacturers using nanoparticles should be aware of the risks that different types of nanoparticles pose to workers who handle them.
Nanoparticles – which can be 10,000 times smaller than the width of a human hair – are potentially hazardous to workers handling the chemicals used to make products as they may be at risk of inhaling them.
New research that provides potential for exciting new approaches to targeting diseases such as cancer has been announced by an international team of academics.
They have also announced the potential for more targeted treatments following their identification of proteins that play a vital role in the life of a human cell.
The research teams from Germany and the UK have published their work in the Advance Online Publication on Nature Cell Biology's website.
Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.
PROVIDENCE, R.I. [Brown University] — One of biggest factors promoting the diversity of coastal ocean life is how fast the water flows, according to new research by ecologists at Brown University. Experiments and observation in Palau, Alaska, and Maine showed that the faster the flow, the greater the number of invertebrate species that live on rocks under the water.
Arlington, Va. — New research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition will highlight a targeted inhalable dry powder vaccine that may prove preferable in terms of needle avoidance and expected lower cost than the current commercial human papillomavirus (HPV) vaccine used throughout the world.
PHILADELPHIA – A research team from the National Cancer Institute (NCI) designated Kimmel Cancer Center (KCC) at Jefferson has concluded – for the first time – that a multidisciplinary clinic approach to aggressive prostate cancer can improve survival in patients. The results from the 15-year study of the multidisciplinary clinic can be found in the November issue of Journal of Oncology Practice.
Stats and Treatment
A new study found that patients with osteoarthritis (OA) of the knee who also have pain in other joints were more likely to experience greater knee pain. Specifically, pain in the lower back as well as foot pain and elbow pain on the same side as the affected knee were associated with more severe knee pain. Full details appear in the December issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
CHICAGO - Testing for 11 specific genetic variations in hundreds of people with no history of heart disease provided information that led to revision of their estimated heart attack risk, say Mayo Clinic researchers.
In a study presented today at the American Heart Association's Scientific Sessions in Chicago, the researchers say that using a genetic score like the one they tested may provide added information to help cardiologists better estimate risk of heart attack in their patients and treat them accordingly.
GOLDEN, Colo. (November 17, 2010) – HealthGrades, the nation's leading independent ratings organization, today made available to organ transplant patients a list of those hospitals with the best track record for survival and chances of receiving a donor organ. HealthGrades annual evaluation of the nation's top-performing hospitals in organ transplantation includes clinical quality data, based on patient outcomes, for each of the 210 adult acute care hospitals that perform transplants.
Research from a six year study on migrating geese has discovered an interesting outcome – they return to the same spots they were taken to as youngsters.
The findings of the study, published online today [November 17] in the journal Molecular Ecology, suggest young light-bellied Brent geese learn their migratory destinations from parents.
The nine-month pregnancy in humans is influenced by the structure of the placenta, according to new research into the evolution of reproduction in mammals which ends a 100-year mystery.
The study, by Durham and Reading universities, shows that babies grow twice as fast in the wombs of some mammals compared to others. The difference in growth rates appears to be due to the structure of the placenta and the way it connects mother and baby.
A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis (TB), according to a study published in Microbiology on 17 November.
The human equivalent of this enzyme has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies. Scientists at the University of Birmingham have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.
Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.